on 25 Feb 2020
Last Applicant/ Owned by
NL-3584 CT Utrecht
NL
Serial Number
79253337 filed on 15th Nov 2018
Registration Number
5993053 registered on 25th Feb 2020
Correspondent Address
Mark Lerner
Filing Basis
No Filing Basis
Disclaimer
NO DATA
Pharmaceutical and veterinary preparations, namely, pharmaceutical preparations based on antibodies, bi- and multispecific antibodies as well as antibody fragments, including monovalent antibodies, derivatives or conjugates of any of these for use with regard to the treatment of cancer, infectious, immune, autoimmune, inflammatory, neurodegenerative and cardiovascular diseases DUO HEXA BODY ChemRead More
Chemical, biochemical, biological, and biotechnological preparations, namely, antibodies, bi- and multispecific antibodies as well as antibody fragments, including monovalent antibodies, and derivatives or conjugates of any of these, for in vitro and in vivo scientific and industrial research and development with regard to diseases; Active chemical ingredients for use in the manufacture of pharmaceuticals
Pharmaceutical and veterinary preparations, namely, pharmaceutical preparations based on antibodies, bi- and multispecific antibodies as well as antibody fragments, including monovalent antibodies, derivatives or conjugates of any of these for use with regard to the treatment of cancer, infectious, immune, autoimmune, inflammatory, neurodegenerative and cardiovascular diseases
Medical, scientific and biological research, especially research into antibodies and bi- and multispecific antibodies or fragments, including monovalent antibodies, derivatives or conjugates of any of these and development of pharmaceutical products based on antibodies and bi- and multispecific antibodies or fragments, including monovalent antibodies, derivatives or conjugates of any of these; chemical analysis; computer programming, namely, programming of computers for the collection and processing of medical data in medical scientific research, development and therapy, including scientific research, development and therapy with antibodies and bi- and multispecific antibodies or fragments, including monovalent antibodies, derivatives or conjugates of any of these
Legal services in the field of patent exploitation, namely, patent consultation, patent licensing, and providing information about patent rights; licensing of intellectual property in the field of medicine
No 79253337
No Service Mark
No 106961-0015
No
No
No
No
No
No
No
No
| Status Date | Action Taken |
|---|---|
| 10th Jul 2020 | FINAL DECISION TRANSACTION PROCESSED BY IB |
| 22nd Jun 2020 | FINAL DISPOSITION PROCESSED |
| 22nd Jun 2020 | FINAL DISPOSITION NOTICE SENT TO IB |
| 25th May 2020 | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB |
| 25th Feb 2020 | REGISTERED-PRINCIPAL REGISTER |
| 10th Dec 2019 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| 10th Dec 2019 | PUBLISHED FOR OPPOSITION |
| 20th Nov 2019 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| 05th Nov 2019 | ASSIGNED TO LIE |
| 31st Oct 2019 | APPROVED FOR PUB - PRINCIPAL REGISTER |
